grobtekrebssvindl, thanks for the link
I had not seen that interview. I think it would go a really long way if Generex would bring in some fresh blood. Somebody with both Scientific chops and Management chops, of which M. Fletcher has neither. Bringing in someone with positive experience running a developmental-stage biotech would maybe assuage some of the restless, disgruntled longs and also attract some newbie investors.
The question is if anybody good would even take the job!
GLTY
"There are three kinds of lies: lies, damned lies, and statistics."